JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winnard, P. T.
Right arrow Articles by Pomper, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winnard, P. T., Jr.
Right arrow Articles by Pomper, M. G.
Journal of Nuclear Medicine Vol. 49 No. Suppl_2 96S-112S
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.045948

Molecular Imaging of Metastatic Potential

Paul T. Winnard, Jr., Arvind P. Pathak, Surajit Dhara, Steven Y. Cho, Venu Raman and Martin G. Pomper

Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For correspondence or reprints contact: Martin G. Pomper, Johns Hopkins Medical Institutions 1550 Orleans St., 492 CRB II Baltimore, MD 21231. E-mail: mpomper{at}jhmi.edu

If molecular imaging is to prove clinically useful it will have to surpass current, primarily anatomic techniques in terms of sensitivity and the ability to detect minimal changes in tissue. One of the most important tests for molecular imaging is to determine whether it can image the metastatic potential of tumors. Like all predictive endeavors, the imaging of such "potential" is a daunting task, but one that only molecular imaging—rather than standard, anatomic techniques—is likely to solve. Although difficult, imaging of metastatic potential is also arguably the most important task for molecular imaging of cancer because it is generally the dissemination of malignant tissue, not its prolonged residence in an inopportune site, which kills the patient. Below are examples of uses of molecular imaging of metastases as well as of metastatic potential, the former being a far more developed area of clinical inquiry.

Key Words: magnetic resonance imaging • radiopharmaceutical • PET • SPECT • optical imaging • bioluminescence • fluorescence • metastasis

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.